STAT+: FDA says it will publish reports of adverse events tied to drugs on daily basis
\n \t
\n
<\/BR>
\n
\n \t
\n
<\/BR><\/p>\n
WASHINGTON \u2014 The Food and Drug Administration announced Friday that it has begun publishing reports of adverse events concerning drugs and biological products on a daily basis. Previously, the database of the reports, called the FDA Adverse Event Reporting System, was updated quarterly<\/a>.\u00a0<\/p>\n \u201cPeople who navigate the government\u2019s clunky adverse event reporting websites should not have to wait months for that information to become public,\u201d FDA Commissioner Marty Makary said in a statement. \u201cWe\u2019re closing that waiting period and will continue to streamline the process from start to finish.\u201d<\/p>\n The move reflects Makary\u2019s desire to improve safety surveillance of products after they hit the market. The commissioner has spoken at length about his goal of harnessing electronic health records<\/a> to better detect safety signals and evaluate efficacy. Health secretary Robert F. Kennedy Jr. has also spoken about improving the agency\u2019s surveillance systems \u2014\u00a0mostly when it comes to vaccines<\/a>, of which he has long been critical.\u00a0<\/p>\n Continue to STAT+ to read the full story\u2026<\/a><\/p>\n<\/div>\n